TSS
PTCT icon

Two Sigma Securities’s PTC Therapeutics PTCT Stock Holding History

Two Sigma Securities’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-8,500
Closed -$408K – 2110
2019
Q4 		$408K Sell
8,500
-1,700
-17% -$72.2K ﹤0.01% 1576
2019
Q3 		$345K Buy
+10,200
New +$444K ﹤0.01% 1440

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Two Sigma Securities's PTCT Position: Q2 2026 in Review

Two Sigma Securities opened a new position in PTC Therapeutics (PTCT) in Q2 2026: 2,883 shares worth $235K. The stake represents 0.02% of the portfolio and ranks #1063 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in PTCT as recently as Q1 2023.

Two Sigma Securities first reported a position in PTCT in Q1 2023 and has held it in 2 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Two Sigma Securities held 2,883 shares of PTC Therapeutics worth $235K as of Q2 2026.
  • PTC Therapeutics was a new Two Sigma Securities position in Q2 2026.
  • PTC Therapeutics made up 0.02% of Two Sigma Securities's portfolio in Q2 2026, its #1063 holding.
  • Two Sigma Securities first reported a position in PTC Therapeutics in Q1 2023 and has held it in 2 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.